What is the treatment for a retroperitoneal hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Retroperitoneal Hematoma

CT imaging with IV contrast or CT angiography (CTA) is the first-line diagnostic approach for retroperitoneal hematoma, followed by either conservative management for hemodynamically stable patients or interventional procedures for unstable patients. 1, 2

Diagnostic Approach

Initial Imaging

  • CT abdomen/pelvis with IV contrast or CT angiography (CTA) is the gold standard for diagnosis 1, 2

    • CTA has better sensitivity than invasive angiography for detecting active bleeding (can detect bleeding rates as low as 0.3 mL/min) 1
    • Provides exact location of hematoma and can identify potential causes (groin access, pelvic fracture, mass)
    • Can evaluate for active extravasation of contrast material
  • Ultrasound is generally not appropriate for initial diagnosis due to:

    • Limited evaluation of retroperitoneal structures
    • Poor sensitivity for detecting smaller volumes of blood
    • Cannot reliably determine if bleeding is active 1
  • Aortography may be considered in:

    • Hemodynamically unstable patients with high suspicion for retroperitoneal hemorrhage
    • Cases of known active arterial bleeding
    • Situations where simultaneous diagnosis and treatment are needed 1, 2

Management Algorithm

1. For Hemodynamically Stable Patients:

  • Conservative management is first-line approach 2, 3, 4:
    • Fluid resuscitation
    • Blood transfusion as needed
    • Correction of coagulopathy (if present)
    • Close monitoring with serial hemoglobin measurements
    • Follow-up CT scan within 24-72 hours if concerns about hematoma expansion 2

2. For Hemodynamically Unstable Patients or Failed Conservative Management:

  • Endovascular intervention 2, 3, 5:

    • Selective intra-arterial embolization for identified bleeding vessels
    • Stent-graft deployment over punctured vessels (particularly for iatrogenic cases)
    • Success rates of approximately 89% have been reported 5
  • Surgical intervention (reserved for specific scenarios) 2, 3:

    • Failure of conservative and endovascular measures
    • Unavailability of endovascular facilities/expertise
    • Persistent hypotension unresponsive to volume resuscitation
    • Progressive fall in hematocrit despite conservative measures
    • Abdominal compartment syndrome requiring decompression

Special Considerations

For Anticoagulated Patients

  • Higher risk of significant bleeding 2
  • May require temporary discontinuation of anticoagulation if bleeding is severe
  • Correction of coagulopathy is critical

For Post-Catheterization Hematomas

  • Most common after coronary artery stenting (prevalence ~3%) 6
  • Risk factors include female sex, excessive anticoagulation, and protocol for sheath removal
  • Clinical signs include suprainguinal tenderness/fullness (100%), severe back/lower quadrant pain (64%), and femoral neuropathy (36%) 6

For Spontaneous Retroperitoneal Hematomas

  • Often associated with anticoagulant therapy 4, 7
  • Can present with sudden onset of flank, abdominal, or back pain
  • May be associated with significant mortality if not promptly diagnosed and treated

Monitoring and Follow-up

  • Monitor vital signs, hemoglobin levels, and clinical symptoms
  • Use ATLS classification to estimate blood volume loss 2
  • Follow-up imaging to assess hematoma resolution
  • Watch for complications such as infection, compression syndromes, or abdominal compartment syndrome

The management of retroperitoneal hematoma requires prompt diagnosis and appropriate intervention based on the patient's hemodynamic status, with CT imaging being the cornerstone of diagnosis and treatment decisions guided by clinical stability.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.